These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 23571259
1. Comparison of outcomes of trabeculectomy with mitomycin C vs. ologen implant in primary glaucoma. Senthil S, Rao HL, Babu JG, Mandal AK, Garudadri CS. Indian J Ophthalmol; 2013 Jul; 61(7):338-42. PubMed ID: 23571259 [Abstract] [Full Text] [Related]
3. Comparison of the Outcomes of Trabeculectomy with 5-Fluorouracil versus Ologen Implant in Primary Open-Angle Glaucoma. Shihadeh W, Massad I, Khader Y, Al-Rawi A, Alshalakhti T. Ophthalmic Res; 2017 Jul; 58(2):94-98. PubMed ID: 28468021 [Abstract] [Full Text] [Related]
6. Outcomes of Trabeculectomy Augmented With Subconjunctival and Subscleral Ologen Implantation in Primary Advanced Glaucoma. Angmo D, Wadhwani M, Upadhyay AD, Temkar S, Dada T. J Glaucoma; 2017 Jan; 26(1):8-14. PubMed ID: 27599174 [Abstract] [Full Text] [Related]
7. Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review. Johnson MS, Sarkisian SR. J Glaucoma; 2014 Dec; 23(9):649-52. PubMed ID: 24240882 [Abstract] [Full Text] [Related]
8. Efficacy and Safety of Ologen Implant Versus Mitomycin C in Primary Trabeculectomy: A Meta-analysis of Randomized Clinical Trials. Ji Q, Qi B, Liu L, Guo X, Zhong J. J Glaucoma; 2015 Dec; 24(5):e88-94. PubMed ID: 25264995 [Abstract] [Full Text] [Related]
10. Trabeculectomy with Ologen versus Mitomycin C in Juvenile Open-Angle Glaucoma: A 1-Year Study. El-Sayyad F, El-Saied HMA, Abdelhakim MASE. Ophthalmic Res; 2017 Dec; 57(4):230-238. PubMed ID: 28291960 [Abstract] [Full Text] [Related]
11. Ex-PRESS outcomes using mitomycin-C, Ologen alone, Ologen with 5-fluorouracil. Menda SA, Lowry EA, Porco TC, Stamper RL, Rubin MR, Han Y. Int Ophthalmol; 2015 Jun; 35(3):357-63. PubMed ID: 24920197 [Abstract] [Full Text] [Related]
12. Outcomes of Trabeculectomy and Phacotrabeculectomy With Collagen Matrix Implant (Ologen) and Low-dose Mitomycin C: 2-Year Follow-up. Castejón MA, Teus MA, Bolivar G, Paz-Moreno-Arrones J, Castaño B. J Glaucoma; 2018 Jan; 27(1):50-54. PubMed ID: 29117004 [Abstract] [Full Text] [Related]
13. Trabeculectomy with combined use of subconjunctival collagen implant and low-dose mitomycin C. Dada T, Kusumesh R, Bali SJ, Sharma S, Sobti A, Arora V, Panda A. J Glaucoma; 2013 Jan; 22(8):659-62. PubMed ID: 23059478 [Abstract] [Full Text] [Related]
15. Ologen implant versus mitomycin C in combined trabeculectomy and phacoemulsification. Paul C, Divya J, Kamal R, Paul A. Indian J Ophthalmol; 2022 Apr; 70(4):1248-1252. PubMed ID: 35326026 [Abstract] [Full Text] [Related]
16. Ologen implant versus mitomycin C for trabeculectomy: a systematic review and meta-analysis. He M, Wang W, Zhang X, Huang W. PLoS One; 2014 Apr; 9(1):e85782. PubMed ID: 24465704 [Abstract] [Full Text] [Related]
17. Combined trabeculotomy-trabeculectomy with and without augmentation in primary congenital glaucoma: triple-armed randomized controlled trial. Khairy MA, Kenawy S, Fawzi KM, Al-Nashar HY. Int Ophthalmol; 2023 May; 43(5):1591-1600. PubMed ID: 36266601 [Abstract] [Full Text] [Related]
18. Trabeculectomy with ologen in secondary glaucomas following failed trabeculectomy with MMC: comparative study. El-Saied HM, Abdelhakim MA. Eye (Lond); 2016 Aug; 30(8):1126-34. PubMed ID: 27256305 [Abstract] [Full Text] [Related]
19. Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial. Cillino S, Di Pace F, Cillino G, Casuccio A. Eye (Lond); 2011 Dec; 25(12):1598-606. PubMed ID: 21921953 [Abstract] [Full Text] [Related]